Trial · NCT03379727
Adverse events604
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 604
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Induction Phase | 34 | 301 | |
| other | Anaemia | Blood and lymphatic system disorders | Consolidation Phase | 36 | 210 | |
| other | Anaemia | Blood and lymphatic system disorders | Maintenance Phaase | 4 | 93 | |
| other | Anaemia | Blood and lymphatic system disorders | Overall | 52 | 301 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Induction Phase | 67 | 301 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Consolidation Phase | 44 | 210 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Maintenance Phaase | 0 | 93 | |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Overall | 88 | 301 | |
| other | Neutropenia | Blood and lymphatic system disorders | Induction Phase | 33 | 301 | |
| other | Neutropenia | Blood and lymphatic system disorders | Consolidation Phase | 50 | 210 | |
| other | Neutropenia | Blood and lymphatic system disorders | Maintenance Phaase | 12 | 93 | |
| other | Neutropenia | Blood and lymphatic system disorders | Overall | 70 | 301 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Induction Phase | 27 | 301 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Consolidation Phase | 40 | 210 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Maintenance Phaase | 6 | 93 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Overall | 51 | 301 | |
| other | Abdominal pain | Gastrointestinal disorders | Induction Phase | 24 | 301 | |
| other | Abdominal pain | Gastrointestinal disorders | Consolidation Phase | 11 | 210 | |
| other | Abdominal pain | Gastrointestinal disorders | Maintenance Phaase | 1 | 93 | |
| other | Abdominal pain | Gastrointestinal disorders | Overall | 34 | 301 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03379727/events